REQUEST A DEMO
Total
USD $0.00
Search more companies

Stada Pharma Cz S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Food Manufacturing | Pharmacies and Drug Stores | Lessors of Other Real Estate Property | Management Consulting Services | Advertising Agencies
Full name: Stada Pharma Cz S.R.O. Profile Updated: January 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

STADA Pharma CZ s.r.o. is the Czech commercial subsidiary of STADA, focused on marketing and distributing a broad portfolio of generic medicines, over the counter products and dietary supplements. The company's assortment includes therapeutic categories such as gastrointestinal health, respiratory care, pain management, dermatology, urology, vitamins and minerals, joint health and pediatric nutrition. Notable consumer brands include Biopron, Walmark, Urinal, Modafen, Nizoral, Lactulose AL, Orofar, Septofort, Martanci, Prostenal, Proenzi, Cetebe, Spektrum and Uroval. STADA Pharma CZ manages marketing activities, regulatory affairs, quality assurance, medical information and pharmacovigilance for its Czech market portfolio. It supplies pharmacies, wholesalers, hospitals and healthcare providers nationwide. Strategically the company positions itself as a provider of high quality, affordable medicines and strong consumer health brands, emphasizing reliability, brand recognition and patient oriented communication within the broader STADA Group framework.

Headquarters
Siemensova 2717/4
Prague; The City of Prague; Postal Code: 15500

Contact Details: Purchase the Stada Pharma Cz S.R.O. report to view the information.

Website: https://www.stada-pharma.cz

Basic Information
Total Employees:
Purchase the Stada Pharma Cz S.R.O. report to view the information.
Registered Capital:
Purchase the Stada Pharma Cz S.R.O. report to view the information.
Financial Auditors:
Purchase the Stada Pharma Cz S.R.O. report to view the information.
Incorporation Date:
May 03, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Stada Pharma Cz S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
3.44%
Total operating revenue
1.06%
Operating profit (EBIT)
20.7%
EBITDA
10.76%
Net Profit (Loss) for the Period
-1.97%
Total Assets
-21.06%
Total Equity
6.16%
Operating Profit Margin (ROS)
0.63%
Net Profit Margin
-0.05%
Return on Equity (ROE)
-0.48%
Quick Ratio
0.04%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?